Drug intelligence / Profile preview

ELIMREAL

Development stage
Unknown
Lead developer
Natac
Modality
Small Molecules
Administration
Oral
01

Overview

ELIMREAL is a patented botanical complex developed by Inoreal (now a part of Natac Group) designed to support body detoxification and natural elimination functions. It is a multi-ingredient blend consisting of six plant extracts: carvi seeds (*Carum carvi*), meadowsweet flower buds (*Spirea ulmaria*), guarana seeds (*Paullinia cupana*), goldenrod plant (*Solidago virgaurea*), fennel fruits (*Foeniculum vulgare*), and dandelion leaves (*Taraxacum dens leonis*). The product is primarily used as a dietary supplement ingredient to stimulate natural body drainage by increasing urinary volume and frequency. Clinical studies have demonstrated its efficacy in increasing urinary excretion by up to 44% at a daily dose of 805 mg, while also providing a sense of detoxification and reducing symptoms associated with heavy legs syndrome. It is marketed globally as a water-soluble ingredient for the nutraceutical industry.

Brand names
ELIMREAL
Other names
Patented natural elimination complexnatural elimination complex

Beyond the preview

Go deeper on ELIMREAL.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ELIMREAL.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call